Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study).

Autor: Tamura, Yuichi1 (AUTHOR) tamura.u1@gmail.com, Kumamaru, Hiraku2 (AUTHOR) kumamaru-tky@umin.ac.jp, Tsujino, Ichizo3 (AUTHOR) itsujino@med.hokudai.ac.jp, Suda, Rika4 (AUTHOR) sudarika@chiba-u.jp, Abe, Kohtaro5 (AUTHOR) abe.kotaro.232@m.kyushu-u.ac.jp, Inami, Takumi6 (AUTHOR) tinami@ks.kyorin-u.ac.jp, Horimoto, Koshin7 (AUTHOR), Adachi, Shiro8 (AUTHOR) sadachi@med.nagoya-u.ac.jp, Yasuda, Satoshi9 (AUTHOR), Sera, Fusako10 (AUTHOR), Taniguchi, Yu11 (AUTHOR) yu.taniguchi007@gmail.com, Kuwana, Masataka12,13 (AUTHOR) kuwanam@nms.ac.jp, Tatsumi, Koichiro4 (AUTHOR) tatsumi@faculty.chiba-u.jp
Zdroj: Pharmaceuticals (14248247). May2024, Vol. 17 Issue 5, p555. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje